Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Tricentis raises fresh capital

logo Tricentis © Tricentis

The financing is for the purpose of further expansion, and is designed to enable even more aggressive growth for the experts in automated software testing. Top customers include BMW, Toyota and Starbucks.

"The financing puts additional capital at our disposal to invest in the business and grow more aggressively“, said Tricentis co-founder and sales manager in a press release.

Operating globally

According to Tricentis’ own information, the company supports more than 400 companies with its software, including HBO, Whole Foods, Toyota, Allianz, BMW, Starbucks and Deutsche Bank. The company has offices in Austria, Germany, Switzerland, Netherlands, Poland, Great Britain, USA, Australia and India..

Insight Venture Partners has already provided funding totaling USD 13 billion to more than 250 companies.

Link: www.tricentis.com

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • 17. Mittelstandstag FrankfurtRheinMain

    07.11.2019, Frankfurt on the Main, Germany

  • MEDICA 2019

    18.11.- 21.11. 2019, Dusseldorf, Germany, Germany

Austria Map

Find the perfect location for your company

Inspite of higher labor costs, the productivity of Siemens Villach is comparable to other Siemens susidiaries in Japan or the USA.

Siemens Austria

Logo
More testimonials

news from the business location Austria

Siemens: New robot welding plant in Graz

Siemens Mobility has put a new robot-controlled frame welding facility into operation in Graz.

Coming back for seconds: Why big brands expand their (R&D) presence in Austria

The high-tech multinational Infineon is investing more than EUR 1.6 billion to expand its main facility in Austria. The pharmaceutical company Octapharma is massively expanding its Vienna-based operations at a cost of EUR 142 million. Headlines like these have recently caused people to sit up and take notice. But the question is: why is Austria as a research location so popular with international firms which are already established here?

More news All blog posts